RxDoctor Payments Data

Heather Anderson

Family · Camilla, GANPI 1184375800

Payments from drug & device makers

$2,100in general payments, 2019–2025

Across 115 payments — averaging $18.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$416
  • Bayer$309
  • Dexcom, Inc.$222
  • Boehringer Ingelheim$189
  • Amgen$170
  • Novo Nordisk$161
  • plus $632 from 13 others

What the payments were for

  • Food & beverage$2,100100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,100 in reported general payments places this provider in the 80th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$32,112
Medicare patients
160
Services billed
861

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$40,631
FarxigaDapagliflozin Propanediol30$40,536
MounjaroTirzepatide30$32,999
LinzessLinaclotide24$29,831
OzempicSemaglutide29$27,979
TrulicityDulaglutide24$26,929
JanuviaSitagliptin Phosphate14$22,039
JardianceEmpagliflozin13$13,582
Spiriva RespimatTiotropium Bromide11$5,457
Breo ElliptaFluticasone/Vilanterol12$4,624
Atorvastatin Calcium203$1,996
Albuterol Sulfate HfaAlbuterol Sulfate54$1,422
Ezetimibe19$1,375
Diclofenac Sodium54$1,137
Losartan Potassium126$1,094

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$416$59,92854 claims
GSKTrelegy Ellipta, Breo Ellipta$99$45,25558 claims
AstraZenecaFarxiga$136$40,53630 claims
AbbVieLinzess$18$29,83124 claims
Novo NordiskOzempic$161$27,97929 claims
MerckJanuvia$118$22,03914 claims
Boehringer IngelheimJardiance, Spiriva Respimat$189$19,03824 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,258 family providers in Georgia.

Other family in Camilla

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →